{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:40:10Z","timestamp":1770684010223,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,4]],"date-time":"2011-09-04T00:00:00Z","timestamp":1315094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00702-011-0708-4","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T12:47:44Z","timestamp":1315313264000},"page":"353-362","source":"Crossref","is-referenced-by-count":24,"title":["Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"119","author":[{"given":"Hana","family":"P\u0159ikrylov\u00e1 Vranov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Mare\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Hlu\u0161t\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Nevrl\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Stejskal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Zapletalov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radko","family":"Obereigneru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Ka\u0148ovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,4]]},"reference":[{"key":"708_CR1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/jnnp.2009.199950","volume":"81","author":"G Alves","year":"2010","unstructured":"Alves G, Br\u00f8nnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C et al (2010) CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson\u2019s Disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 81:1080\u20131086","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"708_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","volume":"843","author":"K Arima","year":"1999","unstructured":"Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Ueda K et al (1999) Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in Lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies. Brain Res 843:53\u201361","journal-title":"Brain Res"},{"key":"708_CR3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","volume":"129","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K et al (2006) CSF amyloid-beta-peptides in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia. Brain 129:1177\u20131187","journal-title":"Brain"},{"key":"708_CR1008","doi-asserted-by":"crossref","unstructured":"Blennow K, Nellg\u013ard B (2004) Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 62(1):159\u2013160","DOI":"10.1212\/WNL.62.1.159"},{"key":"708_CR4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","volume":"77","author":"DJ Burn","year":"2006","unstructured":"Burn DJ, Rowan EN, Allan LM, Molloy S, O\u2019Brien JT, McKeith IG (2006) Motor subtype and cognitive decline in Parkinson\u2019s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:585\u2013589","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"708_CR5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","volume":"70","author":"TC Buter","year":"2008","unstructured":"Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D (2008) Dementia and survival in Parkinson\u2019s disease. Neurology 70:1017\u20131022","journal-title":"Neurology"},{"key":"708_CR6","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"708_CR7","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","volume":"24","author":"Y Compta","year":"2009","unstructured":"Compta Y, Mart\u00ed MJ, Ibarretxe-Bilbao N, Junqu\u00e9 C, Valldeoriola F, Mu\u00f1oz E et al (2009) Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson\u2019s disease. Mov Disord 24:2203\u20132210","journal-title":"Mov Disord"},{"key":"708_CR8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","volume":"26","author":"A Esposito","year":"2007","unstructured":"Esposito A, Dohm CP, Kermer P, B\u00e4hr M, Wouters FS (2007) Alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton. Neurobiol Dis 26:521\u2013531","journal-title":"Neurobiol Dis"},{"key":"708_CR9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM et al (2007) Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64:343\u2013349","journal-title":"Arch Neurol"},{"key":"708_CR10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0028-3932(95)90866-P","volume":"33","author":"V Goel","year":"1995","unstructured":"Goel V, Grafman J (1995) Are the frontal lobes implicated in `planning\u2019 functions? Interpreting data from the Tower of Hanoi. Neuropsychologia 33:623\u2013642","journal-title":"Neuropsychologia"},{"key":"708_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1531-8257(199901)14:1<10::AID-MDS1005>3.0.CO;2-4","volume":"14","author":"JM Graham","year":"1999","unstructured":"Graham JM, Sagar HJ (1999) A data-driven approach to the study of heterogeneity in idiopathic Parkinson\u2019s disease: identification of three distinct subtypes. Mov Disord 14:10\u201320","journal-title":"Mov Disord"},{"issue":"5","key":"708_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427\u2013442","journal-title":"Neurology"},{"issue":"3","key":"708_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","volume":"120","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM et al (2010) Biomarker discovery for Alzheimer\u2019s disease, frontotemporal lobar degeneration, and Parkinson\u2019s disease. Acta Neuropathol 120(3):385\u2013399","journal-title":"Acta Neuropathol"},{"key":"708_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"708_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000113679","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 5:118\u2013121","journal-title":"Neurodegener Dis"},{"key":"708_CR16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"key":"708_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109:329\u2013339","journal-title":"J Neural Transm"},{"key":"708_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A et al (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115:417\u2013425","journal-title":"Acta Neuropathol"},{"key":"708_CR19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159","journal-title":"Annu Rev Neurosci"},{"key":"708_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jnnp.2003.033530","volume":"76","author":"SJ Lewis","year":"2005","unstructured":"Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson\u2019s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343\u2013348","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"708_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1468-1331.2007.02046.x","volume":"15","author":"E Lyros","year":"2008","unstructured":"Lyros E, Messinis L, Papathanasopoulos P (2008) Does motor subtype influence neurocognitive performance in Parkinson\u2019s disease without dementia? Eur J Neurol 15:262\u2013267","journal-title":"Eur J Neurol"},{"key":"708_CR1002","doi-asserted-by":"crossref","unstructured":"Mattila PM, Koskela T, R\u00f6ytt\u00e4 M, Lehtim\u00e4ki T, Pirttil\u00e4 TA, Ilveskoski E et al (1998) Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol 96(4):417\u2013420","DOI":"10.1007\/s004010050913"},{"key":"708_CR1005","doi-asserted-by":"crossref","unstructured":"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M et al (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302(4):385\u2013393","DOI":"10.1001\/jama.2009.1064"},{"key":"708_CR22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000094871","volume":"22","author":"B Mollenhauer","year":"2006","unstructured":"Mollenhauer B, Trenkwalder C, von Ahsen N, Bibl M, Steinacker P, Brechlin P et al (2006) Beta-amyloid 1\u201342 and tau-protein in cerebrospinal fluid of patients with Parkinson\u2019s disease dementia. Dement Geriatr Cogn Disord 22:200\u2013208","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Suppl 3","key":"708_CR23","first-page":"482","volume":"17","author":"R Obereigneru","year":"2010","unstructured":"Obereigneru R, Obereigneru K, Cakirpaloglu S, Reiterova E, Kanovsky P (2010) Tower of Hanoi and the new administration rules for effective executive functions diagnostics. Eur J Neurol 17(Suppl 3):482","journal-title":"Eur J Neurol"},{"key":"708_CR24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archneurol.2010.118","volume":"67","author":"OC Okonkwo","year":"2010","unstructured":"Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ et al (2010) Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol 67:688\u2013696","journal-title":"Arch Neurol"},{"key":"708_CR1007","doi-asserted-by":"crossref","unstructured":"Ost M, Nyl\u00e9n K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkels\u00f6 C et al (2006) Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67(9):1600\u20131604","DOI":"10.1212\/01.wnl.0000242732.06714.0f"},{"key":"708_CR1000","doi-asserted-by":"crossref","unstructured":"Pan S, Shi M, Jin J, Albin RL, Lieberman A, Gearing M et al (2007) Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Mol Cell Proteomics 6(10):1818\u20131823","DOI":"10.1074\/mcp.M700158-MCP200"},{"key":"708_CR25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathological basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50:743\u2013755","journal-title":"J Neuropathol Exp Neurol"},{"key":"708_CR26","doi-asserted-by":"crossref","unstructured":"P\u0159ikrylov\u00e1 Vranov\u00e1 H, Mare\u0161 J, Nevrl\u00fd M, Zapletalov\u00e1 J, Hlu\u0161t\u00edk P, Ka\u0148ovsk\u00fd P (2010) CSF markers of neurodegeneration in Parkinson\u2019s disease. J Neural Transm 117:1177\u20131181","DOI":"10.1007\/s00702-010-0462-z"},{"key":"708_CR1003","unstructured":"Qureshi HY, Paudel HK (2011) Parkinsonian neurotoxin MPTP and alpha-synuclein mutations promote tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem 286(7):5055\u20135068"},{"key":"708_CR27","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","volume":"67","author":"A Rajput","year":"2006","unstructured":"Rajput A, Dickson DW, Robinson CA, Ross OA, D\u00e4chsel JC, Lincoln SJ et al (2006) Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67:1506\u20131508","journal-title":"Neurology"},{"key":"708_CR28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","volume":"73","author":"AH Rajput","year":"2009","unstructured":"Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73:206\u2013212","journal-title":"Neurology"},{"key":"708_CR29","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","journal-title":"Brain"},{"issue":"11","key":"708_CR30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 6(11):1054\u20131061","journal-title":"Nat Cell Biol"},{"issue":"12","key":"708_CR31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","volume":"75","author":"A Siderowf","year":"2010","unstructured":"Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A et al (2010) CSF amyloid {beta}1-42 predicts cognitive decline in Parkinson disease. Neurology 75(12):1055\u20131061","journal-title":"Neurology"},{"key":"708_CR32","volume-title":"A compendium of neuropsychological tests","author":"O Spreen","year":"1998","unstructured":"Spreen O, Strauss E (1998) A compendium of neuropsychological tests, 2nd edn. Oxford University Press, New York","edition":"2"},{"key":"708_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5507\/bp.2005.037","volume":"149","author":"D Stejskal","year":"2005","unstructured":"Stejskal D, Vavrou\u0161kov\u00e1 J, Mare\u0161 J, Urb\u00e1nek K (2005) Application of new laboratory marker assays in neurological diagnosis\u2014a pilot study. Biomed Pap 149:265\u2013267","journal-title":"Biomed Pap"},{"key":"708_CR1004","unstructured":"Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH et al (2003) Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289(16):2094\u20132103"},{"issue":"8","key":"708_CR34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.23116","volume":"25","author":"SM Rooden van","year":"2010","unstructured":"van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review. Mov Disord 25(8):969\u2013978","journal-title":"Mov Disord"},{"issue":"1","key":"708_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.23346","volume":"26","author":"SM Rooden van","year":"2011","unstructured":"van Rooden SM, Colas F, Mart\u00ednez-Mart\u00edn P, Visser M, Verbaan D, Marinus J et al (2011) Clinical subtypes of Parkinson\u2019s disease. Mov Disord 26(1):51\u201358","journal-title":"Mov Disord"},{"issue":"21","key":"708_CR36","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1523\/JNEUROSCI.0297-11.2011","volume":"31","author":"EA Waxman","year":"2011","unstructured":"Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by \u03b1-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31(21):7604\u20137618","journal-title":"J Neurosci"},{"issue":"1","key":"708_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1445-5994.2008.01635.x","volume":"39","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ (2009) How do patients with parkinsonism present? A clinicopathological study. Intern Med J 39(1):7\u201312","journal-title":"Intern Med J"},{"key":"708_CR1006","doi-asserted-by":"crossref","unstructured":"Yao C, Williams AJ, Ottens AK, May Lu XC, Chen R et al (2008) Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats. Brain Inj 22(10):723\u2013732","DOI":"10.1080\/02699050802304706"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0708-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0708-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0708-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T20:59:03Z","timestamp":1560545943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0708-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,4]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0708-4","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,4]]}}}